✦ LIBER ✦

54-4 - Non-cholinergic therapies for Alzheimer's disease

✍ Scribed by V. Kumar; K. Sugaya

Book ID: 118511952
Publisher: Elsevier Science
Year: 1997
Tongue: English
Weight: 280 KB
Volume: 42
Category: Article
ISSN: 0006-3223
DOI: 10.1016/s0006-3223(97)87496-3

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Cholinergic foundations of Alzheimer's d

Cholinergic foundations of Alzheimer's disease therapy

✍ Ezio Giacobini 📂 Article 📅 1998 🏛 Elsevier Science 🌐 English ⚖ 434 KB

Do cholinergic therapies have disease-mo

Do cholinergic therapies have disease-modifying effects in Alzheimer’s disease?

✍ Marwan N. Sabbagh; Martin R. Farlow; Normal Relkin; Thomas G. Beach 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 160 KB

Therapies for Alzheimer's disease

✍ Melnikova, Irena 📂 Article 📅 2007 🏛 Nature Publishing Group 🌐 English ⚖ 164 KB

Cholinergic strategies for Alzheimer’s d

Cholinergic strategies for Alzheimer’s disease

✍ J. Winkler; Leon J. Thal; Fred H. Gage; Lisa J. Fisher 📂 Article 📅 1998 🏛 Springer 🌐 English ⚖ 286 KB

Have cholinergic therapies reached their

Have cholinergic therapies reached their clinical boundary in Alzheimer's disease?

✍ Roy W. Jones 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 70 KB

The cholinergic hypothesis suggests that Alzheimer's disease (AD) results from a selective loss in cholinergic neurons with decreased acetylcholine levels. Treatments that increase the level of acetylcholine would be expected to provide clinical benefit. Clinical trials of dietary precursors of acet

41-1 - Subtype-specific muscarinic choli

41-1 - Subtype-specific muscarinic cholinergic therapies in Alzheimer's disease

✍ A.I. Levey 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 279 KB